SQI Diagnostics (CVE:SQD) Shares Down 12.5%

SQI Diagnostics Inc. (CVE:SQD) shares traded down 12.5% on Wednesday . The company traded as low as C$0.11 and last traded at C$0.11, 27,315 shares traded hands during mid-day trading. A decline of 39% from the average session volume of 44,499 shares. The stock had previously closed at C$0.12.

The stock has a 50 day moving average price of C$0.14. The company has a market capitalization of $23.71 million and a PE ratio of -2.19. The company has a current ratio of 2.22, a quick ratio of 1.54 and a debt-to-equity ratio of 281.50.

SQI Diagnostics (CVE:SQD) last issued its quarterly earnings results on Thursday, May 16th. The company reported C($0.01) earnings per share for the quarter. The company had revenue of C$0.42 million during the quarter.

About SQI Diagnostics (CVE:SQD)

SQI Diagnostics Inc, a life sciences company, develops and commercializes proprietary technologies and products for advanced multiplexing diagnostics in Canada. The company offers sqidworks diagnostic platform, a fully-automated microarray processing and analytical system; sqidlite benchtop diagnostic platform, a fully automated bench top microarray processing and analytical system; and sqid-X, a semi-automated bench-top platform.

See Also: Oversold

Receive News & Ratings for SQI Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SQI Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.